期刊文献+

H1-钙结合蛋白在胃癌组织中的表达及其临床意义 被引量:1

Expression of H1-calponin and clinical significance in gastric cancer
下载PDF
导出
摘要 目的分析H1-钙结合蛋白(H1-calponin)在胃癌组织中的表达,探讨其与基质金属蛋白酶2(MMP-2)表达的关系及临床意义。方法应用反转录-聚合酶链反应(RT-PCR)及Western印迹分析检测胃癌组织(n=20)及癌旁正常组织中H1-calponin的mRNA和蛋白表达水平;RT-PCR和明胶酶图检测胃癌组织及癌旁正常组织中MMP-2的mRNA水平及酶活性。结果 Western印迹灰度扫描显示,胃癌组织中H1-calponin表达水平显著低于癌旁正常组织(0.98±0.28vs 3.11±1.37,t=-6.833,P<0.01),而MMP-2的活性显著高于癌旁正常组织(3.48±1.25vs 1.26±0.39,t=7.556,P<0.01),胃癌组织中H1-calponin表达水平与MMP-2活性呈负相关(r=-0.623,P<0.01)。结论 H1-calponin在胃癌组织中表达下调且与MMP-2活性呈负相关,表明其在胃癌发生过程中发挥重要作用。 Objective To investigate the expression level of H1-calponin and analyze its relationship with matrix metalloproteinase 2(MMP-2) expression level as well as their clinical significance in gastric cancer. Methods Reverse transcription-polymerase chain reaction(RT-PCR) and Western blotting were performed to detect H1-calponin mRNA and protein levels in gastric cancer( n = 20) or adjacent normal gastric mucosa tissues. Zymography and RT-PCR were used to detect the activity and mRNA levels of MMP-2, respectively,in gastric cancer or adjacent normal gastric mucosa tissues. Results In gray scale scanning with Western blotting, H1-calponin gene expression of gastric cancer was significantly lower than that of adjacent normal gastric mucosa tissues (0.98± 0.28 vs 3.11 ±1.37, t =- 6. 833, P 0.01). MMP-2 activity in gastric cancer cases was significantly higher than that in adjacent normal gastric mucosa tissues (3.48±1.25 vs 1.26±0.39, t = 7. 556, P 〈0.01). A negative correlation was found between H1-calponin protein level and MMP-2 activity in gastric cancer tissues (r = -0. 623, P〈 0.01 ). Conclusion H1-catponin expression level is decreased in gastric cancer,which suggested the important role of H1-calponin in gastric cancer.
出处 《临床荟萃》 CAS 2013年第3期252-254,共3页 Clinical Focus
基金 河北省医学科学研究重点课题计划项目(08369)
关键词 胃肿瘤 基质金属蛋白酶2 钙结合蛋白质类 stomach neoplasms matrix metalloproteinase 2 calcium-binding proteins
  • 相关文献

参考文献9

  • 1Lee HJ,Nam KT, Park HS, et al. Gene expression profiling of metaplastie lineages identifies CDH17 as a prognostic marker in early stage gastric cancer[J]. Gastroenterology, 2010,139 ( 1 ): 213-225.
  • 2Gimona M, Kaverina I, Resch GP, et al. Calponin repeats regulate aetin filament stability and formation of podosomes in smooth muscle cells[J]. Mol Biol Cell, 2003,14 (6) : 2482-2491.
  • 3刘伟先,赵伟珠.基因多态性与胃癌个体化治疗的研究进展[J].临床荟萃,2012,27(17):1549-1554. 被引量:5
  • 4Sugaya A,Takeoka M, hano N, et al. Calponin h1-S175T point mutation enhances resistance to actin cytoskeleton perturbation in human cancer cells[J]. Anticancer Res, 2010,30 (4) : 1071- 1078.
  • 5Ferjani I, Fattoum A, Manai M, et al. Two distinct regions of calponin share common binding sites on actin resulting in different modes of ealponin-aetin interaction [J ]. Bioehim Biophys Acta,2010,1804(9) :1760-1767.
  • 6Ogura T, Kobayashi H, Ueoka Y, et al. Adenovirus-mediated calponin hl gene therapy directed against peritoneal dissemination of ovarian cancer: bifunctional therapeutic effects on peritoneal cell layer and cancer cells[J]. Clin Cancer Res, 2006,12(17) :5216-5223.
  • 7李任,沈文斌,祝淑钗,李娟,王玉祥,苏景伟.基质金属蛋白酶2的表达在中晚期食管癌放射治疗中的临床意义[J].临床荟萃,2008,23(3):163-165. 被引量:3
  • 8包晓玲,江秀娟.基质金属蛋白酶9、血管内皮生长因子与肺癌病理类型和TNM分期的关系及临床意义[J].临床荟萃,2010,25(8):658-660. 被引量:3
  • 9Castro MM,Cena J, Cho WJ, et al. Matrix metalloproteinase 2 proteolysis of calponin-1 contributes to vascular hypocontractility in endotoxemic rats[J]. Arterioscler Thromb Vase Biol,2012,32(3) :662-668.

二级参考文献29

  • 1王中华,缪小平,谭文,张湘茹,徐兵河,林东昕.XRCC1单核苷酸多态与晚期非小细胞肺癌对铂类药物化疗敏感性的相关性[J].癌症,2004,23(8):865-868. 被引量:56
  • 2祝淑钗,李任,李娟,邱嵘,韩春,万钧.非手术治疗胸段食管癌临床分期与预后关系的初步探讨[J].中华放射肿瘤学杂志,2004,13(3):189-192. 被引量:70
  • 3朱少伟,罗光华,张晓膺,郑璐,魏江,朱江.非小细胞肺癌中基质金属蛋白酶-10的表达[J].江苏大学学报(医学版),2007,17(3):247-250. 被引量:7
  • 4胡品津.内科学[M].北京:中国协和医科大学出版社,2004.664-670.
  • 5Demirkazik A, Akbulut H, Uiger AF, et al. Serum vascular endothelial growth factor levels in patients with non small cell lung cancer[J]. Ann Saudi Med, 2004,24 (6) : 473-475.
  • 6Matsuyama W, Hashiguchi T, Mizoguchi A. Serum levels of vascular endothelial growth factor dependent on the stage progersion of lung cancer[J]. Chest, 2000,118 (4):948-951.
  • 7Ruokolainen H, Paakko P, Turppeenniemi-Hujanen T. Expression of Matrix metalloproteinase-9 in head and neck squamous cell carcinoma: a potential marker for prognosis[J]. Clin Cancer Res,2004,10(9):310-313.
  • 8Maehara Y,Kabashima A,Koga T,et al. Vascular invasion and potential for tumor angiogenesis and metastasis in gastric carcinoma[J]. Surgery, 2000,128(3) :408-416.
  • 9Karayiannakis AJ, Syrigos KN, Zbar A, et al. Clinical significance of preoperative serum vascular endothelial growth factor levels in patients with colorectal cancer and the effect of tumor surgery[J]. Surgery,2002,131(2):548-555.
  • 10殷蔚伯 张力军 杨宗贻.3 798放射治疗食管癌例临床分析[J].中华肿瘤杂志,1980,2(3):216-218.

共引文献8

同被引文献12

  • 1Katsios C,Ziogas DE,Roukos DH. Targeted therapy for colorectal cancer resistance to EGF receptor antibodies and new trends[J].Expert Rev Gastroenterol Hepatol,2013,(01):5-8.
  • 2Kwon SH,Jeong SW,Jang JY. Cyclooxygenase-2 and vascular endothelial growth factor in chronic hepatitis,cirrhosis and hepatocellular carcinoma[J].Clin Mol Hepatol,2012,(03):287-294.
  • 3Murray NP,Reyes E,Tapia P. Differential expression of matrix metalloproteinase-2 expression in disseminated tumor cells and micrometastasis in bone marrow of patients with nonmetastatic and metastatic prostate cancer:theoretical considerations and clinical implications-an immunocytochemical study[J].Bone Marrow Res,2012.1-9.
  • 4Hu J,Chen C,Su Y. Vascular endothelial growth factor promotes the expression of cyclooxygenase 2 and matrix metalloproteinases in Lewis lung carcinoma cells[J].Exp Ther Med,2012,(06):1045-1050.
  • 5Nedeau AE,Gallagher KA,Liu ZJ. Elevation of hemopexin-like fragment of matrix metalloproteinase-2 tissue levels inhibits ischemic wound healing and angiogenesis[J].{H}Journal of Vascular Surgery,2011,(05):1430-1438.
  • 6Li X,Ji Z,Ma Y. Expression of hypoxia-inducible factor-1α,vascular endothelial growth factor and matrix metalloproteinase-2 in sacral chordomas[J].Oncol Lett,2012,(06):1268-1274.
  • 7Godefroy E,Bhardwaj N. Dysregulation of anti-tumor immunity by the matrix metalloproteinase-2[J].Oncoimmunology,2012,(01):109-111.
  • 8Li Z,He T,Du K. Overexpression of 15-lipoxygenase-1 in oxygen-induced ischemic retinopathy inhibits retinal neovascularization via downregulation of vascular endothelial growth factor-A expression[J].{H}MOLECULAR VISION,2012.2847-2859.
  • 9Pérez-Hernández N,Vargas-Alarcón G,Martinez-Rodriguez N. The matrix metalloproteinase 2-1575 gene polymorphism is associated with the risk of developing myocardial infarction in Mexican patients[J].{H}Journal of Atherosclerosis and Thrombosis,2012,(08):718-727.
  • 10贺娜,刘春英,宋伟,李芊蔚.环氧合酶2抑制剂塞来昔布对结肠癌多药耐药逆转作用的研究[J].临床荟萃,2012,27(11):950-952. 被引量:2

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部